forteo
(Teriparatide)Eli Lilly and Company
Usage: FORTEO is indicated for treating high-risk postmenopausal women and men with osteoporosis, including those intolerant to other therapies. It also increases bone mass in men with primary or hypogonadal osteoporosis and treats osteoporosis related to long-term glucocorticoid use, reducing fracture risk in these populations.